Rohto Pharmaceutical Co Ltd 2023 Integrated Report
Company: Rohto Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 80
The report presents Rohto's FY2022 integrated value-creation story, centered on well-being, with consolidated net sales of 238.6 billion yen and 7,176 consolidated employees as of March 31, 2023. It identifies five materiality issues and links them to SDGs, while describing human-capital initiatives including 30.0% female managers and an October 2022 Well-being Points score of 6.74. The company reports a 46% Scope 1 and 2 reduction target by 2030 against FY2013 and FY2022 emissions of 13,120 tons, although these climate figures are stated on a non-consolidated basis. It also reports value-chain Scope 3 measurement and a broad set of environmental, human-rights, supply-chain, and community initiatives.
Services
From bulk PDFs to structured indicators and machine-readable documents.